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Abstract
Oropouche virus (OROV) is responsible for outbreaks of Oropouche fever in parts of South
America. We recently identified and isolated OROV from a febrile Ecuadorian patient, how-
ever, a previously published qRT-PCR assay did not detect OROV in the patient sample. A
primer mismatch to the Ecuadorian OROV lineage was identified from metagenomic
sequencing data. We report the optimisation of an qRT-PCR assay for the Ecuadorian
OROV lineage, which subsequently identified a further five cases in a cohort of 196 febrile
patients. We isolated OROV via cell culture and developed an algorithmically-designed
primer set for whole-genome amplification of the virus. Metagenomic sequencing of the
patient samples provided OROV genome coverage ranging from 68–99%. The additional
cases formed a single phylogenetic cluster together with the initial case. OROV should be
considered as a differential diagnosis for Ecuadorian patients with febrile illness to avoid
mis-diagnosis with other circulating pathogens.
Author summary
Oropouche virus (OROV) causes outbreaks of febrile illness in areas of South and Central
America and we recently identified it in Ecuador for the first time, using metagenomic
sequencing. The genome sequence data revealed that the Ecuadorian strain of the virus
was not detected using a published qRT-PCR, as it differed genetically at the binding site
of the reverse primer. To address this, we developed a modified qRT-PCR that showed
increased sensitivity for the Ecuadorian strain. This test detected OROV infection in 6 out
of 196 febrile patients from Esmeraldas, Ecuador in 2016. OROV was isolated from
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positive patient samples, viral genome sequences were compared to publicly available
OROV sequences. This revealed that the Ecuadorian cases are genetically distinct, suggest-
ing that local transmission of the virus should not be ruled out. This work highlights the
need for a better understanding of OROV dynamics in Ecuador and surrounding areas,
the importance of considering OROV as a cause of fever in Ecuadorian patients and the
possibility of selectively using metagenomic sequencing in parallel to traditional molecu-
lar techniques in patient testing.
Introduction
Oropouche virus (OROV) is the causative agent of Oropouche fever, an arboviral illness that is
usually self-limiting and mild but in rare cases infects the central nervous system and causes
meningitis [1,2]. The virus belongs to the genus Orthobunyavirus, family Peribunyaviridae,
and has a negative-sense, single-stranded RNA genome composed of three segments. The
small (S) segment (0.95 kb) encodes the nucleoprotein (N) and non-structural protein (NSs),
the medium (M) segment (4.36 kb) encodes a polyprotein consisting of two glycoproteins
(Gn, Gc) and one non-structural protein (NSm), whilst the large (L) segment (6.85 kb)
encodes the RNA dependent RNA polymerase (RdRP) [3].
OROV is one of the most clinically important orthobunyaviruses in the Americas, with
over half a million cases and more than 30 major outbreaks reported since it was first isolated
in Trinidad and Tobago in 1955 [4]. These figures are likely to be underestimates, caused in
part by underreporting due to the similar clinical presentation of other arboviral diseases that
co-circulate in the same areas, including dengue virus (DENV), chikungunya virus (CHIKV),
Mayaro virus (MAYV), yellow fever virus (YFV) and Zika virus (ZIKV) [4,5]. The primary
vector species implicated in urban OROV transmission is the biting midge Culicoides paraen-
sis. This is well supported by both experimental and epidemiological data (reviewed in 5). It
has been suggested that the widely distributed mosquito species Culex quinquefasciatus may
contribute to OROV transmission during outbreaks, although efficiency of transmission has
been shown experimentally to be lower than that of the primary vector [1]. Cases of Oro-
pouche fever have been reported in Brazil, Peru, Panama, and Trinidad and Tobago [5]. We
recently isolated OROV for the first time from a patient in north-western Ecuador [6] suggest-
ing that OROV may be circulating undetected in this region. This led us to further investigate
the presence of OROV in an additional 196 febrile patients from the same coastal area of
Esmeraldas, Ecuador, sampled in 2016.
Reverse transcription polymerase chain reaction (RT-PCR) is typically used for the detec-
tion of viral RNA directly from clinical samples [7–10]. The rate of detection of OROV RNA
in patient plasma during the first five days of illness is reported as 93.3% using a one-step real-
time RT-PCR (qRT-PCR) [7]. A disadvantage of RT-PCR is that a conserved target genome
sequence is required, making it difficult to detect viral strains that are genetically divergent,
reassortant, novel, or of an unexpected virus species. Metagenomic sequencing (untargeted
sequencing of all genetic material in a sample) is an attractive alternative to conventional
molecular detection methods as it does not require prior knowledge of pathogen genome
sequences. For example, an established OROV qRT-PCR [7] was unable to detect OROV in
the plasma of an Ecuadorian febrile patient who tested positive using metagenomic sequencing
and virus isolation (S segment sequence available at GenBank, accession MF926352.1) [6].
This highlights the potential for misdiagnosis when screening for pathogens that lack a large
collection of reference sequences on which to base targeted amplification. Here we report (i)
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the development of a qRT-PCR with improved sensitivity, (ii) an algorithmically-designed
[16] primer set for whole-genome amplification of OROV, and (iii) the prevalence of OROV
in the 2016 Esmeraldas patient cohort.
Materials and methods
Patient samples
Plasma samples were obtained from patients at Delfina Torres de Concha Hospital, Esmeral-
das province, Ecuador, in 2016 (n = 196) and 2017 (n = 62), along with metadata: patient age,
sex, patient location, number of days of fever, and other clinical signs and symptoms.
Ethics statement
Blood samples were obtained from Delfina Torres de Concha Hospital (Esmeraldas city, Ecua-
dor), from febrile patients who attended the hospital voluntarily and submitted their blood for
routine dengue and Zika virus testing. The use of these samples in this project was approved
by the Universidad San Francisco de Quito bioethics committee. Samples were anonymised
prior to analysis and the patients were not required to fill out informed consent.
RNA extraction and PCR assays
Plasma samples were spiked with bacteriophage MS2 (1.45 x 105 pfu) as an internal control.
RNA was extracted using the QIAamp Viral RNA mini kit (Qiagen) following manufacturer’s
instructions, substituting the addition of carrier RNA with the same volume of linear poly-
acrylamide (LPA). A negative extract control (molecular-grade water) was included in each
batch of extractions. RNA was screened using Public Health England in-house diagnostic PCR
and RT-PCR assays, some of which were adapted from published assays, targeting: DENV
[11], CHIKV (in-house), ZIKV [12], YFV [11], MAYV (in-house), Plasmodium spp. [13], Lep-
tospira spp. (in-house) and Rickettsia spp. [14,15].
Metagenomic sequencing
DNAse treatment, cDNA preparation, random amplification by SISPA (Sequence-Indepen-
dent Single Primer Amplification), and Illumina sequencing were performed as described pre-
viously [17]. Reads were trimmed to remove adaptors and low-quality bases using
trimmomatic (0.3.0) [18] with default parameters, to achieve an average phred score of Q30
across the read.
Taxonomic analysis of reads was undertaken using Centrifuge (Galaxy Version 1.0.3-beta)
[19] with index "Bacteria, Archaea, Viruses, Human", last updated on 12/06/2016, available at
https://ccb.jhu.edu/software/centrifuge/manual.shtml, on a local instance of Galaxy [20]. Map-
ping to OROV genomes was performed using BWA MEM (v0.7.15) [21], using OROV/EC/
Esmeraldas/087/2016 (GenBank accessions MF926352.1, MF926353.1, MF926354.1) as refer-
ences. Quasibam [22] was used to generate consensus sequences, with a 5x coverage cut off.
Mapping statistics were generated using SAMtools (v1.4) [23]. Alignment and analysis of
nucleotide and protein sequences was performed using the ClustalW method in MegAlign
(v14.0.0). Human reads were removed by mapping to the human genome (human_g1k_v37
[1000 genomes]), non-mapped reads were selected using SAMtools fastq, with flag -F 2. Raw
data (stripped of human reads identified via mapping or Centrifuge) is available from the
Sequence Read Archive, accession numbers SAMN12241859—SAMN12241881. De novo
assembly of non-human reads was performed using SPAdes (v3.8.2) with—meta flag [24]. A
BLASTn [25] search was performed on resulting scaffolds larger than 1000 bp, against
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GenBank (nr/nt) database. Non-human reads were mapped (BWA MEM) to a multifasta file
containing sequences from relevant viruses, including at least one representative genome from
each PCR screening target (CHIKV, OROV, DENV1, DENV2, DENV3, DENV4, MAYV,
YFV, ZIKV), any virus that had appeared during BLAST analysis of de novo assembled scaf-
folds (Hepatovirus A, Rift Valley Fever virus, influenza A virus), and the internal control MS2.
Samples with >0.02% reads assigned to a virus species by Centrifuge or an assembled scaf-
fold larger than 1500 bp showing homology to a viral sequence using BLASTx were investi-
gated for the presence of that specific virus. A positive virus detection was defined as>40%
genome coverage (1x) generated when mapping to a reference genome.
Virus isolation and quantification
Vero cells, freely provided by the European Collection of Authenticated Cell Cultures
(ECACC; catalogue number 84113001), were inoculated with patient plasma diluted 1:10 in
Eagle’s minimum essential medium (MEM) to a volume of 1 mL, incubated at 37˚C with 5%
(v/v) CO2 for 96 hours. Cultures were sampled at 24-hour intervals, virus genome replication
was determined using OROV qRT-PCR. Virus was harvested, filtered (0.2 μm pore, Sartorius)
and stored at -80˚C.
Plaque assays were performed on Vero cell monolayers. 250 μl of 10-fold virus dilutions
were added to cells and incubated for one hour at 37˚C, 5% (v/v) CO2. Inoculum was removed,
then 3 mL overlay medium (2x MEM, 1% NEAA, 1% antibiotic-antimycotic, (Invitrogen), 2
mM L-glutamine (Fisher Scientific), 10% FBS (Sigma-Aldrich), and 1% Seaplaque agarose
(Lonza)) applied and incubated for four days, before fixation and staining using 20% formalin
and 2.3% crystal violet, respectively. Plates were air dried and plaques counted to determine
virus titre, using the lowest dilution showing >10 plaques.
Primer alignment
Primer and probe sequences were aligned using the ClustalW algorithm in the MEGA7 soft-
ware package, to a set of OROV N gene coding sequences (GenBank) representing the geo-
graphic (Brazil, Panama, Peru and Trinidad and Tobago) and temporal diversity of OROV
isolates from the 1950s to present day [26].
qRT-PCR limit of detection analysis
For OROV qRT-PCR assay optimisation (supporting information), a range of primers were
tested (S1 Text and S1 Table) using the Superscript III Platinum One-step Quantitative
RT-PCR kit (Invitrogen) in a standard 25 μL reaction, run on an ABI 7500 real-time PCR
machine (Applied Biosystems). Optimal conditions were 18 μM of each primer, 12.5 μM
probe and standard MgSO4 concentration. Cycling conditions: 50˚C for 10 minutes, 95˚C for
2 minutes, 45 cycles of 95˚C for 10 seconds then 60˚C for 40 seconds (with quantification anal-
ysis of fluorescence performed at the end of each 60˚C step) and a final cooling step of 40˚C
for 30 seconds.
Absolute quantitation of RNA copy number was calculated from a standard curve of target
sequence RNA, transcribed using the Megascript kit (Ambion). A 711 bp region of the S seg-
ment was amplified from cDNA of OROV/EC/Esmeraldas/087/2016, using primers incorpo-
rating a T7 promoter sequence (forward primer sequence 5’ GTC AGA GTT CAT TTT CAA
CGA TGT ACC ACA ACG G 3’, reverse primer sequence 5’ GAA ATT AAT ACG ACT CAC
TAT AGG G CTC CAC TAT ATG TC 3’). RNA was quantified using the Qubit RNA broad
spectrum kit and purity confirmed using the RNA 6000 pico kit on a bioanalyzer (Agilent).
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Multiplex tiling RT-PCR primer design
The S, M and L segment sequences of OROV/EC/Esmeraldas/087/2016 were concatenated
and inputted using default settings to the Primal Scheme [16] webtool (http://primal.
zibraproject.org/), which implements an algorithm for designing multiplex PCR primers for
virus lineages. The designed primer scheme was modified manually to account for segment
ends, incorporating 5’ and 3’ end primers (see supporting information for primer sequences).
RNA from patient sample D-057 and the cell-cultured prototype strain were amplified in
two multiplex PCR reactions using the Ecuador OROV primer scheme designed as described
above. Primer pools were used at 100 μM. Products were visualised by gel electrophoresis and
quantified using Qubit fluorometric quantitation. These were sequenced on a MinION
(Oxford Nanopore, UK) and data processed as previously described [16].
Results
Development of an OROV qRT-PCR
An existing S segment assay [7] failed to detect OROV RNA in an Ecuadorian clinical sample
that tested positive by both metagenomic sequencing and virus isolation (S1 Fig) [6]. The
reverse primer (OROV R) [7] had two mismatches to the novel OROV/EC/Esmeraldas/087/
2016 sequence. We attempted to improve sensitivity by analysing primer and probe suitability.
Two new reverse primers were designed; one with mismatches corrected (Ec R) and one at a
new site (Ec2 R) (S1 Table), based on an alignment of all publicly available OROV S segment
sequences. Testing was performed against both OROV/EC/Esmeraldas/087/2016 and the 1955
prototype Trinidad and Tobago isolate from a distinct lineage (GenBank KP026181.1). The
original reverse primer showed reduced sensitivity for the Ecuadorian strain compared with
the prototype strain, which were detected to the 10−4 and 10−6 dilutions respectively (Fig 1).
Primer Ec R showed improved sensitivity for the Ecuadorian strain but reduced sensitivity for
the prototype strain, with detection possible to the 10−7 and 10−3 dilutions respectively (Fig 1).
Ec2 R improved sensitivity by three logs for the Ecuadorian strain and by one log for the proto-
type strain, compared with the original reverse primer (Fig 1). The final assay using Ec2 R
underwent validation. The standard curve demonstrated a linear relationship between mean
Cq value and log RNA copy number, the absolute limit of detection of the qRT-PCR assay was
10 copies of OROV RNA at a mean Cq value of 38.25 (95% CI 37.8 to 38.7, S2 Fig). No cross-
reactivity was observed in exclusivity testing against 23 virus species (S2 Table) within the
Alphavirus, Flavivirus, Phlebovirus, Orthobunyavirus, Nairovirus and Mammarenavirus gen-
era. Primer and probe sequences were aligned with all publicly available OROV N gene
sequences (n = 149) to identify mismatches that may reduce sensitivity for certain strains. Of
the 149 sequences, 19 had mismatch(es) to the forward primer, 21 sequences showed a mis-
match to the probe, and 26 had mismatch(es) to the original reverse primer OROV R, six of
which were mismatches at two positions (S3 Table). In contrast, no sequence had more than
one mismatch to the new reverse primer Ec2 R, however, the number of sequences with a sin-
gle mismatch was higher (n = 41).
Pathogen identification in febrile patients using PCR
We initially used nine PCR or RT-PCR assays to screen serum from Ecuadorian patients with
undifferentiated febrile illness for pathogens previously reported from the country. Following
our previous metagenomic sequencing based identification of OROV in one of these samples
[6], and improvement of the OROV qRT-PCR, we re-screened all patient samples for OROV.
PCR screening identified positive cases (Cq value<35) of ZIKV (prevalence 11.2%, n = 22),
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DENV (prevalence 2.0%, n = 4), OROV (prevalence 3.1%, n = 6), and Leptospira spp. (preva-
lence 0.51%, n = 1) (Fig 2). In addition, a number of potentially positive cases (Cq value 35–
39.9) were identified (ZIKV n = 15, DENV n = 3, CHIKV n = 2. and Leptospira spp. n = 1, Fig
2). Cq values in this upper range require additional testing to confirm positive status (this was
performed for the Cq>35 OROV sample, but not for the other pathogens). No cases of
MAYV, YFV, Plasmodium spp. or Rickettsia spp. were identified. 147 samples were negative
for all pathogens tested. All samples were qRT-PCR-positive for internal control MS2.
Follow up screening of febrile patient samples from 2017
Sixty-two samples from febrile patients from Esmeraldas, taken in 2017, were tested for
OROV, CHIKV, DENV, MAYV, YFV, ZIKV and Rickettsia spp. by PCR and RT-PCR. All
samples were negative for all pathogens and positive for internal control MS2.
Fig 1. Sensitivity analysis of three reverse primers used in the qRT-PCR assay. Cq values are shown for ten-fold serial dilutions of
OROV RNA, either from the prototype strain (GenBank KP026181.1), or the Ecuadorian strain OROV/EC/Esmeraldas/087/2016
(GenBank MF926352.1). Three separate experiments were performed, from which the means (plotted as data points) and standard
deviations (indicated by error bars) were calculated. Reverse primer sequences (5’–3’) are given in the embedded table.
https://doi.org/10.1371/journal.pntd.0007897.g001
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Pathogen confirmation and genome characterisation using metagenomic
sequencing
All OROV qRT-PCR-positive samples were also OROV-positive by metagenomic sequencing,
demonstrating that detection is possible from patient plasma samples with OROV RNA con-
centrations as low as 9.62e+3 genome copies/mL (S4 Table). Mapping reads to reference
sequence OROV/EC/Esmeraldas/087/2016 resulted in genome coverage ranging from 68–99%
(Fig 3). The proportion of OROV-specific reads does not appear to be particularly strongly
correlated with Cq value, differences in the background level of non-viral RNA (in particular
from the host) could account for this. It was still somewhat indicative of OROV genome cover-
age generated (Fig 3), with coverage generally decreasing as Cq increases. OROV reads were
not detected in any of the 17 pathogen PCR-negative samples also tested. Hepatovirus A
(HAV, formerly hepatitis A virus) was identified in one sample, with 1,894 reads providing
40% genome coverage (Table 1). Reads specific to internal control MS2 were identified in all
PCR-negative samples.
Fig 2. Cq values from 49 pathogen positive or potentially positive plasma samples, from a cohort of 196 screened
by qRT-PCR. Samples with a Cq value of 35–39.9 should be considered potentially positive because (except for the
OROV sample) confirmatory tests were not performed. Lepto = Leptospira spp.
https://doi.org/10.1371/journal.pntd.0007897.g002
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Confirmation of OROV infection in qRT-PCR-positive patients by virus
isolation
OROV was successfully cultured in Vero cells from all five OROV-positive patient plasma
samples (virus was isolated from the initial patient D-087 as previously reported [6]). S seg-
ment copy numbers for all samples increased by at least 5 logs to approximately 1.00e+12 cop-
ies/mL at 72 hours post-infection (S3 Fig), demonstrating that OROV was replicating.
Confirmation of the presence of infectious virus was undertaken by plaque assay using P1
supernatant from the representative isolate OROV/EC/Esmeraldas/087/2016 from patient D-
087, which formed plaques on Vero cells indicating a titre of 1.56e+7 pfu/mL. A subsequent
Fig 3. OROV genome coverage generated from six OROV-positive patient plasma samples, using a metagenomic
sequencing approach. Reads were mapped to reference sequences OROV/EC/Esmeraldas/087/2016 (GenBank
accessions MF926352.1- MF926354.1). Panel A: OROV genome segment (S, M, L) coverage (%). qRT-PCR Cq value is
given at the top of each plot. Coverage is defined as a minimum of 5 reads at any given position. Panel B: OROV
genome coverage shown as the number of reads at each genomic position. Plots are separated by genome segment (S,
M, L). Red dashed line indicates 5x coverage.
https://doi.org/10.1371/journal.pntd.0007897.g003
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passage (P2) on Vero cells, also assessed by plaque assay, further confirmed the presence of
infectious virus.
RNA from cultured viral supernatant (one passage in Vero cells) underwent metagenomic
sequencing and the resulting reads were mapped to reference genome OROV/EC/Esmeraldas/
087/2016. Complete genomes were generated from all isolates and are available on GenBank,
accession numbers MK506818—MK506832.
The genomes were 99.7–100% identical to one another in the S segment and 99.9–100%
identical in the M and L segments. Single nucleotide polymorphisms (SNPs) were observed at
33 positions throughout the genome, all of which occurred in coding regions (S5 Table).
Alignment of protein sequences showed that the N protein was 100% identical between iso-
lates, whilst the NSs protein had a single amino acid substitution in isolate D-206. Isolate D-
210 had two amino acid substitutions in the M protein, whilst three isolates (D-057, D-155
and D-206) had one substitution in this protein. Two isolates (D-155 and D-210) had a single
amino acid substitution in the L protein (S6 Table). Of the eight substitutions seen, five consti-
tute a reactive (R) group change (three on the M segment and two on the L segment) and
therefore may influence the structure or function of the protein.
The genome sequences from the patient and cultured sequences were compared to identify
SNPs incurred during passage. The number of SNPs per genome ranged from one (sample D-
057) to 15 (sample D-155) (S7 Table). The majority of changes were from a mixed population
(mixed defined as no one base occupying >80% of reads at a position) in the patient, to either
a different mixed population, or a majority population (majority defined as one base occupy-
ing >80% reads at a position) in the cultured isolate (S8 Table). Changes from a majority pop-
ulation in the patient were less common, seen at two (samples D-171 and D-210) to five
(sample D-087) positions, with sample D-057 showing no changes of this type (S8 Table).
Only one of the 49 positions with polymorphisms between patient and cultured sequences was
conserved between isolates (M segment position 59, S8 Table).
Development of an OROV multiplex tiling RT-PCR primer scheme
Samples with lower levels of viral RNA often present challenges in generating complete
genome sequences using the metagenomic sequencing approach (Table 1 and Fig 3). To
address this problem, a set of targeted genome amplification primers was designed using the
algorithmic method described by Quick et al. [16] (S2 Text). Using a cut-off of 20x read depth,
>99% coverage of all three Ecuadorian OROV genome segments was obtained (average
Table 1. Viruses identified from 23 patient plasma samples by metagenomic sequencing, 17 of which were negative for all pathogens tested for by RT-PCR, includ-
ing one sample (D-087) in which OROV was initially detecting by metagenomic sequencing. The remaining five samples (D-057, D-155, D-171, D-206 and D-210)
were initially shown to be positive for OROV using the qRT-PCR assay described in this study. The cut-off value used was�40% genome coverage (from mapping reads to
reference genome).
Sample
ID
Virus
identified
% of total reads assigned by
Centrifuge
Reads assigned by
Centrifuge
Reads mapped to reference
sequence
1x genome
coverage (%)
Mapping reference (accession
number)
D-005 HAV 0.02 478 1,894 40 LC049339.1
D-057 OROV 7.42 143,925 870,960 99 MF926352.1–54.1
D-087 OROV 0.70 5,084 9,972 80 MF926352.1–54.1
D-155� OROV 1.97 66,686 24,274 90 MF926352.1–54.1
D-171� OROV 3.13 94,248 145,146 95 MF926352.1–54.1
D-206 OROV 0.63 25,050 277,019 68 MF926352.1–54.1
D-210 OROV 4.15 78,747 733,986 92 MF926352.1–54.1
�Data are from two separate sequencing runs combined.
https://doi.org/10.1371/journal.pntd.0007897.t001
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coverage of 7,075x, 9,894x and 7,381x for the S, M and L segments, respectively) directly from
clinical sample D-057 (Fig 4). For the prototype strain, 98% of the S segment (average
coverage = 126,860x), 93% of the M segment (average coverage = 119x) and 92% of the L seg-
ment (average coverage = 189x) were obtained, despite its sequence divergence from the Ecua-
dorian strains.
Discussion
Using metagenomic sequencing followed by screening using an optimised qRT-PCR, we have
detected a cluster of six OROV cases from patients local to Esmeraldas, Ecuador, providing
further evidence that OROV may be causing an unrecognised burden of human disease in pre-
viously unreported areas.
Some of these cases were not detected by the previously published assay due to a primer
mismatch with the Ecuadorian genomes, which was identified in the metagenomic sequencing
data. This discovery highlights the problems in developing amplification-based detection
assays for pathogens with limited numbers of sequenced genomes, and the benefits offered by
unbiased sequencing technologies. Although the cost associated with metagenomic sequencing
may be prohibitive for frontline diagnosis in developing countries, it can be used in prospec-
tive screening studies to identify potential issues with qRT-PCR assays and allow for alterations
to increase inclusivity, as reported here. We developed a new reverse primer for the previously
published assay that improves sensitivity for both the Ecuadorian strain (capable of detecting
10 copies of target RNA) and the genetically divergent prototype strain. Other OROV strains
were not available to validate against, however an alignment of all publicly available strains
showed that the majority of sequences are homologous to the primer/probe sequences. The
qRT-PCR amplifies a region in the S segment, the target sequence of which is shared by a num-
ber of reassortant orthobunyaviruses, including Iquitos virus, which is known to circulate in
neighbouring Peru and can cause Oropouche fever [27]. This modified assay also has the
potential to detect reassortant orthobunyaviruses containing the OROV S segment. An algo-
rithmically-designed multiplex primer set was developed that can amplify the majority of the
genome from both the Ecuadorian and prototype strains and may be a useful tool for sequenc-
ing OROV genomes from clinical samples with low viral titres.
Virus identification in the Ecuadorian cohort was undertaken initially using PCR. In addi-
tion to OROV, screening identified the presence of ZIKV, DENV, Leptospira spp. and possibly
CHIKV nucleotide sequences. These pathogens are known to circulate in Ecuador [28–30];
ZIKV in particular was widespread in the Americas (including Ecuador) at the time of sam-
pling [31], so the identification of a relatively large number of ZIKV cases (n = 22 positive,
n = 15 potentially positive) was not unexpected. Cq values of 35–39.9 were observed for multi-
ple samples across all identified pathogens. Samples with values in this range require confirma-
tory testing to be certain of the presence of the pathogen.
Metagenomic sequencing of 17 PCR-negative samples identified HAV sequence in one
patient; no other viruses were conclusively identified. Ecuador is considered an ‘intermediate
endemicity’ country for HAV [32] and therefore identification of this virus is not unexpected.
The lack of viral sequences from the majority of the patient samples could be explained by a
number of factors including clearance of virus from the blood by the time of sampling, or fever
caused by non-infectious disease. Metagenomic sequencing successfully identified OROV in
all OROV qRT-PCR-positive patients, with good genome coverage (68–99%), suggesting that
this method is effective for both detection and characterisation of OROV genomes from clini-
cal samples. Sequencing of one sample (D-206) produced M and L segment-specific reads that
mapped to the reference sequence, however only two reads mapping to the S segment. The
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absence of S segment signal here is simply due to the stochastic nature of the metagenomic
sequencing method, which is exacerbated for smaller fragments. The S segment is both
detected by qRT-PCR (at a Cq value of 30.9, the second highest value of all six OROV-positive
patients) and is present in the sequencing of the virus directly cultured from this sample.
The generation of complete viral genomes using metagenomic sequencing or a multiplex
tiling RT-PCR (as opposed to the small fragments generated using conventional qRT-PCR)
enables more detailed and accurate molecular epidemiological analyses [33]. Initial phyloge-
netic analysis of S, M and L segments showed that the five additional Ecuadorian genomes
cluster in a monophyletic group with our previously reported Ecuadorian strain, suggesting
the possibility of local transmission within Esmeraldas. An investigation of potential OROV
vector species in Esmeraldas would be highly informative. The group is most closely related to
strain TVP-19256/IQE-7894 from Peru, 2008 (GenBank KP795084.1—KP795086.1). A com-
prehensive phylogenetic analysis of OROV in South America, including the Ecuadorian
genomes, has been undertaken [26].
It is well-documented that mutations occur during passaging in vitro [34]. Our study gener-
ated complete genome sequences from viruses that had undergone one passage in Vero cells.
The single passage was necessary to amplify virus and generate complete genome sequences,
however, passaging was limited to minimise the number of mutations between patient and cul-
tured viral genomes. A number of positions in the OROV patient genomes showed a mixed
population of variants, which progressed to a majority population in the cultured genome.
Majority-majority changes were rare and only one of the 49 SNPs observed between patient
and cultured genomes was shared in two individual strains.
No cases of OROV were detected during follow-up qRT-PCR screening of 62 febrile
patients from Esmeraldas, 2017. Previous outbreaks of Oropouche fever have been episodic
Fig 4. Genome coverage of two OROV strains (Ecuadorian strain OROV/EC/Esmeraldas/087/2016 Genbank MF926352.1—
MF926354.1, and prototype strain Genbank KP026179.1—KP026181.1), sequenced using a MinION (Oxford Nanopore), from
multiplex tiling RT-PCR amplicons. Plots are separated by genome segment (S, M, L). Red dashed line indicates 20x coverage.
https://doi.org/10.1371/journal.pntd.0007897.g004
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and self-limited in nature [4]; the six cases identified from 2016 could represent a single out-
break that ended that year. Alternatively, if OROV transmission did occur in Esmeraldas in
2017, the lack of detection could be related to the limited sample size of the cohort. A larger-
scale study is necessary to determine the prevalence and distribution of OROV in the Ecuador-
ian population.
OROV infection should be considered when diagnosing Ecuadorian patients with febrile
illness. We hope that the molecular tools developed in this study will be useful for laboratories
performing viral diagnostics and surveillance in the Americas. Very little is known about the
dynamics of OROV in Ecuador or endemicity in neighbouring regions; the detection of
OROV in multiple febrile patients warrants further investigation into its prevalence, associated
vectors, and transmission.
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